Centrica Updates and Secures FCA Approval for $10bn EMTN Base Prospectus

The latest announcement is out from Centrica ( (GB:CNA) ).

Centrica has updated and received Financial Conduct Authority approval for a new base prospectus under its existing U.S.$10 billion Euro Medium Term Note Programme, dated 14 May 2026. The document, which underpins the company’s ability to issue notes in the European debt markets, is now available online and will also be accessible via the FCA’s National Storage Mechanism, reinforcing Centrica’s funding flexibility and transparency for fixed-income investors.

The most recent analyst rating on (GB:CNA) stock is a Buy with a £225.00 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.

Spark’s Take on CNA Stock

According to Spark, TipRanks’ AI Analyst, CNA is a Neutral.

Overall score is driven primarily by mid-tier financial performance: strong revenue momentum and consistently positive free cash flow are offset by volatile bottom-line results (net loss in 2025) and a balance sheet that remains only moderately stable. Technicals are mildly supportive with the stock holding above key longer-term moving averages and neutral momentum. Valuation is reasonable with a moderate P/E and dividend yield.

To see Spark’s full report on CNA stock, click here.

More about Centrica

Centrica plc is a UK-based energy company that operates across the utility sector, supplying gas and electricity and related energy services to residential, commercial, and industrial customers. It is a major participant in European energy markets and frequently accesses debt capital markets to support its operational and investment needs.

Average Trading Volume: 20,733,022

Technical Sentiment Signal: Buy

Current Market Cap: £9.21B

Learn more about CNA stock on TipRanks’ Stock Analysis page.